A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for
curative treatment in form of resection or transplantation. There are different treatment …

Purpose We sought to report outcomes and toxicity in patients with hepatocellular carcinoma
(HCC) who received resin yttrium-90 selective internal radiation therapy (90Y-SIRT) and to …

Selective internal radiation therapy (SIRT) with 90yttrium microspheres is a relatively new
clinical modality for treating non‐resectable malignant liver tumours. This interventional …

Transarterial radioembolization (TARE) with yttrium 90 (90 Y) has been used in the
management of hepatocellular carcinoma (HCC) for more than 10 years in Korea. There are …

Objectives: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-
90 (90 Y) radioembolization in Korean patients with hepatocellular carcinoma (HCC) …

Background Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver
that most commonly presents late in the disease course. As a result, the majority of patients …

Background The purpose of this study was to assess the safety and efficacy of Yttrium-90
radioembolization using in unresectable hepatocellular carcinoma. Methods From 2017 to …

Background Selective internal radiation therapy (SIRT) with yttrium-90 (90Y) resin
microspheres is an established locoregional treatment option for unresectable …

(1) Microspheres containing radioactive yttrium-90 (90Y) are infused into the hepatic artery.
These deliver high doses of ionizing radiation to inoperable hepatocellular carcinoma, the …

Background: Selective Internal Radiation (SIR) therapy with yttrium-90 microspheres has
become an alternative approach to treat hepatic tumors. Methods: A single institution …